Has John Baldauf, MD received payments from drug or device companies?

Yes. Drug and device makers reported $116,977 in general payments to John Baldauf, MD across 509 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean John Baldauf, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about John Baldauf, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

John Baldauf, MD

Orthopaedic Surgery · Las Vegas, NVNPI 1891773479

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $90,363 of the $116,977 with a category attached, or 77.2%. Encore Medical, LP accounts for 76.1% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2019 at $54,954 and has fallen 81.0% since, to $10,447 in 2025. Among orthopaedic surgery clinicians in NV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$116,977in general payments, 2019–2025

Across 509 payments — averaging $229.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Encore Medical, LP$89K
Medacta USA, Inc.$20K
Stryker$4K
Pacira Therapeutics, Inc.$2K
Ferring Pharmaceuticals Inc.$1K
Sanara Medtech Inc.$376
plus $979 from 13 others

What the payments were for

Consulting fees$90,36377%
Travel & lodging$9,6228%
Food & beverage$16,98515%
Education$80%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Encore Medical, LP	59	$89,015
Medacta USA, Inc.	157	$19,606
Stryker	40	$3,807
Pacira Therapeutics, Inc.	115	$1,767
Ferring Pharmaceuticals Inc.	92	$1,428
Sanara Medtech Inc.	9	$376
Johnson & Johnson(3 entities)	10	$183
Pacira Pharmaceuticals Incorporated	4	$174
Vertex	5	$172
Skeletal Dynamics Inc	1	$115
Boston Scientific	4	$70
Acera Surgical, Inc.	3	$63
Heron Therapeutics, Inc.	3	$52
Smith+Nephew	1	$38
Xtant Medical Inc	1	$34
Anika Therapeutics, Inc.	2	$33
Avanos Medical	1	$17
Si-bone, Inc.	1	$14
Intuitive Surgical	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

DJO Surgical Empowr Knee System$76,349
DJO Surgical AltiVate Reverse$66,411
DJO Surgical TaperFill Hip System$56,580
DJO Surgical AltiVate Anatomic System$31,628
DJO Surgical FMP Acetabular System$30,713
DJO Surgical Exprt Revision Hip$10,800
DJO Surgical Linear Hip System$9,225
DJO Surgical Exprt Revision Knee$9,225
PRIMARY SHOULDER$7,767
GMK Sphere Revision System$2,043
AMISTEM$1,607
MAKO$1,538
GMK SPHERE$1,436
AMIStem H Femoral Stems$809
DJO Surgical CLP Hip System$504
DJO Surgical 3DKnee System$498
GMK REVISION$369
INSIGNIA$339
REUNION$285
AEQUALIS PERFORM REVERSED$280

How this compares

$116,977 in reported general payments places this provider in the 90th percentile of 135 orthopaedic surgery providers in Nevada.

See all orthopaedic surgery providers in Nevada →

Medicare billing

Part B allowed, 2024

$698,532

Medicare patients

797

Services billed

33,852

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Piroxicam	17	$378
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	16	$192
Ibuprofen	15	$130
Tramadol Hcl	18	$63
Meloxicam	13	$53
Amoxicillin	23	$28

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Las Vegas

Mark BarryLas Vegas$9.5M
Erik KubiakLas Vegas$7.8M
Russell NevinsLas Vegas$1.5M
Vladimir SinkovLas Vegas$434K
Ronald HillockLas Vegas$275K
Galen KamLas Vegas$270K
Michael DaubsLas Vegas$215K
Brian CarrLas Vegas$91K
Brandon RomeroLas Vegas$72K
Matthew BudgeLas Vegas$71K

See the full list for Nevada →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →